Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local oral pilocarpine drops for dry mouth in elderly patients
NL-OMON48076Phase 2Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pilocarpine in xerostomia (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Change in xerostomia score and Change in oral health-related quality of life. Started Jun 2019; status: active, not recruiting.
02
Drugs
pilocarpine
03
Conditions
xerostomia
Beyond the preview
Go deeper on NL-OMON48076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48076.